United States · Funded startup

Who invested in 4E Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.5Mraised across 1 round since 2021, from 1 source

Latest round
Grant, $5.5MNov 2021
Investors
1
See who backed them

The rounds

  1. Nov 2021
    Grant$5.5M

    Source recordedSEC filing: $1.9M sold, first sale Oct 2021

Founders and team

From the SEC filings it signed: 1 on the team.

  • Thomas Craig BensonExecutive Officer, Directori

On the board, as filediEric Craig PriceJoseph Craig PriceTheodore Craig Price

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about 4E Therapeutics

Who invested in 4E Therapeutics?

4E Therapeutics's investors include National Institutes of Health.

How much has 4E Therapeutics raised?

4E Therapeutics has raised $5.5M across 1 round since 2021.

When did 4E Therapeutics last raise?

4E Therapeutics's most recent round was a Grant of $5.5M in Nov 2021.

What was 4E Therapeutics's biggest round?

Its most recent round, $5.5M in Nov 2021, is also its largest on record.

Who backed 4E Therapeutics first?

4E Therapeutics's first round on record, in Nov 2021, was backed by National Institutes of Health.

What stage is 4E Therapeutics at?

4E Therapeutics's latest named round is a Grant, in Nov 2021.

Where is 4E Therapeutics based?

4E Therapeutics is based in the United States.

Companies like 4E Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.